Conmed Corp
NYSE:CNMD
Conmed Corp
NYSE:CNMD
Price:
68.34 USD
0.53%
Market Closed
Updated:
May 2, 2024
Conmed Corp
Revenue
|
Conmed Corp
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Conmed Corp
NYSE:CNMD
|
Revenue
$1.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Conmed Corp
Revenue Breakdown
Breakdown by Geography
Conmed Corp
Conmed Corp
|
Total Revenue:
1.2B
USD
|
|
United States:
700.2m
USD
|
|
EMEA:
226.3m
USD
|
|
Asia Pacific:
197.4m
USD
|
|
Americas (Excluding The United States):
120.9m
USD
|
Breakdown by Segments
Conmed Corp
Conmed Corp
|
Total Revenue:
1.2B
USD
|
|
General Surgery:
711.6m
USD
|
|
Orthopedic Surgery:
533.2m
USD
|
See Also
What is Conmed Corp's Revenue?
Revenue
1.2B
USD
1.2B
USD
Based on the financial report for Dec 31, 2023, Conmed Corp's Revenue amounts to 1.2B USD.
What is Conmed Corp's Revenue growth rate?
Revenue CAGR 10Y
5%
5%
Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for Conmed Corp have been 13% over the past three years , 8% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
